Cryo-em structure of mycobacterium tuberculosis transcription activation complex with four phop molecules (composite map) Deposition Author(s): Feng, Y. , Lin, W.
Date: 2024-11-05 Method: ELECTRON MICROSCOPY Resolution: 3.7 Å Organism(s): Mycobacterium Tuberculosis H37Rv , Synthetic Construct Sequences Data: 9KEU_A , 9KEU_B , 9KEU_C , 9KEU_D , 9KEU_E , 9KEU_H , 9KEU_G , 9KEU_F , 9KEU_J , 9KEU_K , 9KEU_M , 9KEU_I
Cryo-em structure of mycobacterium tuberculosis transcription activation complex with six phop molecules (composite map) Deposition Author(s): Feng, Y. , Lin, W.
Date: 2024-11-05 Method: ELECTRON MICROSCOPY Resolution: 3.31 Å Organism(s): Mycobacterium Tuberculosis H37Rv , Synthetic Construct Sequences Data: 9KEV_A , 9KEV_B , 9KEV_C , 9KEV_D , 9KEV_E , 9KEV_H , 9KEV_G , 9KEV_F , 9KEV_J , 9KEV_K , 9KEV_M , 9KEV_L , 9KEV_N , 9KEV_O
Kras g12v and peptide complex Deposition Author(s): Ha, M.S. , Han, C.W. , Jang, S.B.
Date: 2024-11-06 Method: X-RAY DIFFRACTION Resolution: 3.45 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 9KFL_A , 9KFL_D , 9KFL_E , 9KFL_H , 9KFL_K , 9KFL_P , 9KFL_Y
Crystal structure of synthetic ppr-dyw in complex with target rna Deposition Author(s): Gutmann, B. , Ichinose, M. , Kakuta, Y. , Nakamura, T. , Okada, A. , Teramoto, T. , Urushihara, R. , Yagi, Y.
Date: 2024-11-07 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Synthetic Construct , Synthetic Construct Sequences Data: 9KFX_A , 9KFX_B , 9KFX_R
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.37 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGJ_A , 9KGJ_B , 9KGJ_C , 9KGJ_D
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.89 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGN_B , 9KGN_A , 9KGN_C , 9KGN_D
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGQ_B , 9KGQ_A , 9KGQ_C , 9KGQ_D
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-08 Method: X-RAY DIFFRACTION Resolution: 1.47 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGR_A , 9KGR_B , 9KGR_C , 9KGR_D
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity Deposition Author(s): Baburajendran, N.
Date: 2024-11-09 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 9KGS_B , 9KGS_A , 9KGS_C , 9KGS_D
Crystal structure of topoisomerase iv from klebsiella pneumoniae in complex with dna and bwc0977, a dual-targeting broad-spectrum novel bacterial topoisomerase inhibitor. Deposition Author(s): Aoki, M. , Balasubramanian, V. , Datta, S. , Hameed, S. , Katagihallimath, N. , Murakami, S. , Okada, U. , Ramachandran, V. , Yamashita, E.
Date: 2024-11-09 Method: X-RAY DIFFRACTION Resolution: 3.05 Å Organism(s): Klebsiella Pneumoniae Subsp. Pneumoniae Mgh 78578 , Synthetic Construct Sequences Data: 9KGT_A , 9KGT_B , 9KGT_C , 9KGT_D , 9KGT_E , 9KGT_F , 9KGT_G , 9KGT_H